AI-generated · cited to primary sources · not investment advice
The company has implemented remediation measures including improved third-party information reviews and additional finance controls, with completion still targeted for year-end 2025. (1 in progress, 1 revised, 1 met across 3 tracked commitments)
“The Company performed an annual assessment as of June 30, 2025 and will not remain eligible for EGC status as of December 31, 2025.”
As of September 30, 2025, the company has used $48.7 million in operating activities, which is on track to meet the full-year guidance of $65.0 million to $80.0 million. (1 in progress, 1 missed across 2 tracked commitments)
“We expect our total net cash used in operating activities for 2025 to be in the range of $65.0 million to $80.0 million.”
Management expects to complete the remediation of its material weakness in internal controls by the end of 2025. — target: December 31, 2025 (+2 more commitments)
“We expect that the remediation of this matter that was deemed a material weakness will be fully complete no later than December 31, 2025.”
See the full cited Management analysis of Oklo Inc. Class A common stock
The company expanded its business model through the acquisition of Atomic Alchemy, adding a radioisotope production stream to its core nuclear power and recycling focus. (1 new, 1 expanding)
“On February 28, 2025, the Company entered into a stock purchase agreement pursuant to which it acquired 100% of the common stock outstanding of Atomic Alchemy... to combine Oklo’s expertise in building and operating fast reactors and nuclear fuel recycling with Atomic Alchemy’s expertise in its radioisotope business.”
Operating losses are expanding as the company scales its R&D and G&A headcount to meet development milestones, with net loss increasing nearly 200% year-over-year for the quarter. (1 contracting)
“Net loss: Three Months Ended September 30, 2025: $(29,722); 2024: $(9,960).”
See the full cited Business Model analysis of Oklo Inc. Class A common stock
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.